Difficulty: Medium
Average Score: 74%
Practice
Of the following, the drug that is MOST likely associated with drug-induced lupus is
Correct answer
A
Rationale
The correct answer is A) isoniazid. Isoniazid is a medication commonly used to treat tuberculosis. Drug-induced lupus is a rare side effect associated with certain medications, including isoniazid. It is believed to result from the body's immune response to the drug, leading to symptoms similar to systemic lupus erythematosus.
Rifampin (option B) is not typically associated with drug-induced lupus. It is a medication also used to treat tuberculosis but does not commonly cause lupus-like symptoms.
Nitrofurantoin (option C) is an antibiotic used to treat urinary tract infections. While it can cause side effects like pulmonary reactions, it is not a known cause of drug-induced lupus.
Penicillin (option D) is an antibiotic commonly used to treat various infections. Penicillin is not known to be associated with drug-induced lupus.
Educationally, understanding the potential side effects and adverse reactions of medications is crucial for healthcare professionals, especially in pediatric nursing. Recognizing drug-induced lupus as a potential complication of isoniazid can aid in early identification and management of this condition in pediatric patients, ensuring safe and effective care.
Rifampin (option B) is not typically associated with drug-induced lupus. It is a medication also used to treat tuberculosis but does not commonly cause lupus-like symptoms.
Nitrofurantoin (option C) is an antibiotic used to treat urinary tract infections. While it can cause side effects like pulmonary reactions, it is not a known cause of drug-induced lupus.
Penicillin (option D) is an antibiotic commonly used to treat various infections. Penicillin is not known to be associated with drug-induced lupus.
Educationally, understanding the potential side effects and adverse reactions of medications is crucial for healthcare professionals, especially in pediatric nursing. Recognizing drug-induced lupus as a potential complication of isoniazid can aid in early identification and management of this condition in pediatric patients, ensuring safe and effective care.